Abstract
Novel drug delivery systems (NDDS) delivered the active molecules to the target site in a defined manner for produce the desired effects without disturbing the delicate bio-environment. Among many available colloidal drug delivery systems, Liposomes (a class based on phospholipids) have attracted more attention than other systems due to many meritorious features such as excellent chemical & biological stability, good solubilisation power, promote intracellular delivery of bio-active molecules, reduce the uptake of macrophages and encapsulate both hydrophilic as well as lipophillic drug molecule. In this review article, I try to give some basic knowledge about these carrier systems in tabular form, which is more understandable concept as compared to simple text form.
Keywords: Cell delivery, drug targeting, gene delivery, liposome, phospholipids.
Drug Delivery Letters
Title:Liposomes: Targeted and Controlled Delivery System
Volume: 4 Issue: 1
Author(s): Tarun Garg and Amit K. Goyal
Affiliation:
Keywords: Cell delivery, drug targeting, gene delivery, liposome, phospholipids.
Abstract: Novel drug delivery systems (NDDS) delivered the active molecules to the target site in a defined manner for produce the desired effects without disturbing the delicate bio-environment. Among many available colloidal drug delivery systems, Liposomes (a class based on phospholipids) have attracted more attention than other systems due to many meritorious features such as excellent chemical & biological stability, good solubilisation power, promote intracellular delivery of bio-active molecules, reduce the uptake of macrophages and encapsulate both hydrophilic as well as lipophillic drug molecule. In this review article, I try to give some basic knowledge about these carrier systems in tabular form, which is more understandable concept as compared to simple text form.
Export Options
About this article
Cite this article as:
Garg Tarun and K. Goyal Amit, Liposomes: Targeted and Controlled Delivery System, Drug Delivery Letters 2014; 4 (1) . https://dx.doi.org/10.2174/22103031113036660015
DOI https://dx.doi.org/10.2174/22103031113036660015 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |
Call for Papers in Thematic Issues
Nanomaterial Assisted Targeted Therapies for Chronic Disorders- Preclinical to Clinical Outcomes
In recent years, the integration of nanomaterials into therapeutic strategies has emerged as a promising avenue in the pursuit of more effective treatments for chronic disorders. This dynamic field, explored in the context of "Nanomaterial Assisted Targeted Therapies for Chronic Disorders - Preclinical to Clinical Outcomes," seeks to bridge the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Endless Journey of Adenosine Signaling in Cardioprotective Mechanism of
Conditioning Techniques: Clinical Evidence
Current Cardiology Reviews Gender Differences in the Treatment of Ischemic Heart Disease
Current Pharmaceutical Design New Approaches to the Modulation of the Cyclooxygenase-2 and 5-Lipoxygenase Pathways
Current Topics in Medicinal Chemistry subject Index To Volume 1
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Oxidative Stress and its Clinical Consequences: Relationship between Diabetes and Cancer
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Inflammatory Markers in Coronary Artery Disease: Pathophysiological Mechanisms, Prognostic and Therapeutic Implications
Current Cardiology Reviews Propofol Rescued Astrocytes from LPS-induced Inflammatory Response via Blocking LncRNA-MEG3/NF-κB Axis
Current Neurovascular Research Protein Kinase C – Possible Therapeutic Target to Treat Cardiovascular Diseases
Cardiovascular & Hematological Disorders-Drug Targets Cannabinoid Modulation of Neuroinflammatory Disorders
Current Neuropharmacology Fingolimod (FTY720) Reduces Cortical Infarction and Neurological Deficits During Ischemic Stroke Through Potential Maintenance of Microvascular Patency
Current Neurovascular Research Statin Therapy-Evidence Beyond Lipid Lowering Contributing to Plaque Stability
Current Medicinal Chemistry Dendritic Cell Immunotherapy for Malignant Gliomas
Reviews on Recent Clinical Trials DDX3X Deficiency Attenuates Pyroptosis Induced by Oxygen-glucose Deprivation/Reoxygenation in N2a Cells
Current Neurovascular Research Single-Photon Emission Computed Tomography Tracers for Predicting and Monitoring Cancer Therapy
Current Pharmaceutical Biotechnology Multi-target Pharmacological Effects of Platycodin D
Mini-Reviews in Organic Chemistry Regulation of Oxidative Stress and Cardioprotection in Diabetes Mellitus
Current Cardiology Reviews Review on Patents for Ubiquitin-Proteasome Inhibitor as Medical Advance in Major Human Diseases
Recent Patents on Biomedical Engineering (Discontinued) Tailored Angiogenesis Inhibition in Cancer Therapy: Respecting the Heart to Improve the Net Outcome
Current Signal Transduction Therapy Oxidative Stress Induced Mitochondrial DNA Deletion as a Hallmark forthe Drug Development in the Context of the Cerebrovascular Diseases
Recent Patents on Cardiovascular Drug Discovery Vascular Endothelial Dysfunction in Ischemic Reperfusion Injury Needs Constant Updating
Current Drug Targets